Answers are grounded in this paper and cite their sources.
Antibacterial resistance continues to drive the need for exploring novel chemical spaces beyond conventional organic scaffolds. Metal-based compounds have emerged as a promising class of antibiotic candidates, demonstrating high hit rates against priority bacterial pathogens without exhibiting increased toxicity compared to purely organic molecules. Here, we report a one-pot, three-component combinatorial strategy for the synthesis of piano-stool Ir(III) cyclopentadienyl Schiff-base complexes as potential antibacterial agents. Using 15 picolinaldehydes (A–O), 24 amines (1–24), and four Cp/Cp* iridium precursors (Cp1–4), a library of 1440 complexes was generated and screened directly from crude reaction mixtures in a direct-to-biology approach. Biological screening revealed pronounced activity against Gram-positive Staphylococcus aureus, particularly for biphenyl-substituted Cp (Cp2) complexes, while no activity was observed against Gram-negative bacteria. A subset of the compounds exhibited potent and selective antibacterial activity with low mammalian cell toxicity. Dose-response validation identified 4 promising hit candidates, of which Ir15 displayed low-micromolar activity against a panel of Gram-positive pathogens, limited hemolysis, and moderate cytotoxicity. Initial mechanistic studies indicate that Ir15 acts through a membrane-associated mode of action involving mild membrane depolarization without large pore formation, alongside changes in nucleoid morphology. Overall, this work establishes Ir(III)Cp Schiff-base complexes as a modular antibacterial platform and identifies Ir15 as a promising lead compound for further optimization.
No takes yet. Share an insight, caveat, or question.
Özsan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: